HALO:BMV
Halozyme Therapeutics, Inc.
MX$1.955,00
arrow_downward
-0,70%(-13,69) 1D
1 ຕ.ລ., 13 ໂມງ 46 ນາທີ 16 ວິນາທີ GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Mkt. cap
13,40 ຕື້
Avg. vol.
440,00
Volume
0,00
52-wk high
MX$1.970,00
52-wk low
MX$1.126,00
No. of employees
423
Mkt. cap
13,40 ຕື້
Avg. vol.
440,00
Volume
0,00
52-wk high
MX$1.970,00
52-wk low
MX$1.126,00
No. of employees
423
News stories
From web sources and news partners
Investing.com UK
·
1 ຊົ່ວໂມງກ່ອນ
Halozyme Therapeutics stock hits all-time high at 116.85 USD By Investing.com
Yahoo Finance
·
1 ມື້ກ່ອນ
Will Halozyme Therapeutics (HALO) Beat Estimates Again in Its Next Earnings Report?
Investing.com
·
1 ມື້ກ່ອນ
H.C. Wainwright reiterates Halozyme stock rating on FDA approval
Investing.com
·
1 ມື້ກ່ອນ
Halozyme director Matthew Posard sells $567,660 of common stock
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
Headquartersແຊນ ດີເອໂກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitehalozyme.com